(Q38003198)

26 August 2017

title

Treatment options for acute depression in bipolar disorder (English)

1 reference

26 August 2017

1 reference

Philipp Ritter

2

0 references

Heinz Grunze

object named as

Heinz Grunze

series ordinal

3

0 references

Andrea Pfennig

series ordinal

4

object named as

Andrea Pfennig

1 reference

26 August 2017

1

Michael Bauer

1 reference

26 August 2017

publication date

1 May 2012

1 reference

26 August 2017

1 reference

26 August 2017

volume

14 Suppl 2

1 reference

26 August 2017

page(s)

37-50

1 reference

Retrospective age at onset of bipolar disorder and outcome during two-year follow-up: results from the STEP-BD study.

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00991.X

Association between age of onset and mood in bipolar disorder: comparison of subgroups identified by cluster analysis and clinical observation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00991.X

Treatment-latency and previous episodes: relationships to pretreatment morbidity and response to maintenance treatment in bipolar I and II disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00991.X

Long-term implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00991.X

Mood episodes and mood disorders: patterns of incidence and conversion in the first three decades of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00991.X

ECNP consensus meeting. Bipolar depression. Nice, March 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00991.X

Suicide attempts in bipolar I and bipolar II disorder: a review and meta-analysis of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00991.X

Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00991.X

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00991.X

Balanced efficacy, safety, and tolerability recommendations for the clinical management of bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00991.X

Clinical and therapeutic implications of predominant polarity in bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00991.X

Clinical practice. Bipolar disorder--a focus on depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00991.X

Treatment-resistant bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00991.X

Bipolar depression: criteria for treatment selection, definition of refractoriness, and treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00991.X

The clinical management of bipolar disorder complexity using a stratified model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00991.X

The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00991.X

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00991.X

Grading quality of evidence and strength of recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00991.X

Quality of reporting of randomized controlled trials of pharmacologic treatment of bipolar disorders: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00991.X

Moclobemide vs. imipramine in bipolar depression: a multicentre double-blind clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00991.X

Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00991.X

Effectiveness of adjunctive antidepressant treatment for bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00991.X

Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00991.X

A double-blind study of L-sulpiride versus amitriptyline in lithium-maintained bipolar depressives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00991.X

Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00991.X

A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00991.X

Paroxetine and amitriptyline augmentation of lithium in the treatment of major depression: a double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00991.X

Comparison of paroxetine and amitriptyline as adjunct to lithium maintenance therapy in bipolar depression: a reanalysis of a randomized, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00991.X

A single blind comparison of lithium and lamotrigine for the treatment of bipolar II depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00991.X

A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00991.X

Adjunctive herbal medicine with carbamazepine for bipolar disorders: A double-blind, randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00991.X

A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00991.X

Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00991.X

Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00991.X

Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00991.X

Psychosocial treatments for bipolar depression: a 1-year randomized trial from the Systematic Treatment Enhancement Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00991.X

Left prefrontal transcranial magnetic stimulation (TMS) treatment of depression in bipolar affective disorder: a pilot study of acute safety and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00991.X

Vagus nerve stimulation: 2-year outcomes for bipolar versus unipolar treatment-resistant depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00991.X

A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00991.X

Behavioral engagement level, variability, and diurnal rhythm as a function of bright light in bipolar II seasonal affective disorder: an exploratory study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00991.X

Sustained antidepressant effect of sleep deprivation combined with pindolol in bipolar depression. A placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00991.X

Ongoing lithium treatment prevents relapse after total sleep deprivation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00991.X

Lithium specificity in bipolar illness: a classic agent for the classic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00991.X

Optimal frequency of lithium administration in the treatment of bipolar disorder: clinical and dosing considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00991.X

The lithiumeter: a measured approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00991.X

Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00991.X

Divalproex in the treatment of bipolar depression: a placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00991.X

Tranylcypromine versus imipramine in anergic bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00991.X

CONSORT 2010: Aktualisierte Leitlinie für Berichte randomisierter Studien im Parallelgruppen-Design

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00991.X

Efficacy and Safety of Lamotrigine as Add-On Treatment to Lithium in Bipolar Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2012.00991.X

10.1111/J.1399-5618.2012.00991.X

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference